Related Experiment Video
Updated: Mar 19, 2026
09:48
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
838
Small molecule targeting miR-34a for cancer therapy
Zhangang Xiao1, Yangchao Chen2
1School of Biomedical Sciences; Faculty of Medicine; The Chinese University of Hong Kong ; Shatin, Hong Kong.
Molecular & Cellular Oncology
|June 17, 2016
Summary
Rubone, a small molecule, shows anticancer effects by restoring miR-34a expression in liver cancer cells. This suggests a new therapeutic strategy for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNA-34a (miR-34a) acts as a tumor suppressor in various cancers.
- Hepatocellular carcinoma (HCC) is a major global health concern.
- Dysregulation of microRNAs is implicated in cancer development.
Purpose of the Study:
- To investigate the anticancer activity of the small molecule Rubone.
- To determine if Rubone can restore miR-34a expression in cancer cells.
- To evaluate the therapeutic potential of Rubone in hepatocellular carcinoma.
Main Methods:
- Treatment of hepatocellular carcinoma cells with Rubone.
- Assessment of miR-34a expression levels.
- Evaluation of cell viability and anticancer effects.
Main Results:
- Rubone demonstrated significant anticancer activity.
- Rubone selectively restored silenced miR-34a expression in HCC cells.
- Restoration of miR-34a by Rubone correlated with its anticancer effects.
Conclusions:
- Rubone is a promising small molecule with anticancer properties.
- Restoring miR-34a expression is a viable therapeutic strategy for cancer.
- Rubone represents a potential novel treatment for hepatocellular carcinoma.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:57Targeted Cancer Therapies
1.7K
1.7K
01:22MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
01:22MicroRNAs
24.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
02:15Experimental RNAi
8.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K
01:15Drugs that Stabilize Microtubules
2.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K